Metabolism of lipids and lipid proteins CKO vs K5Cre Reactome by Kevin J. Mills (9270966)

Subjects:

Ceramide biosynthetic process CKO vs K5Cre GO: Biological Processes. by Kevin J. Mills (9270966)

Subjects:

Conditional deletion of C/EBP in epidermis results in downregulation of transcripts and pathways associated with lipid biosynthesis in epidermis. by Kevin J. Mills (9270966)

Subjects:

UHPLC-MS CKO vs K5Cre results. by Kevin J. Mills (9270966)

Subjects:

Uncropped raw western blot images. by Kevin J. Mills (9270966)

Subjects:

LC-IMS-CID-MS CKO vs K5Cre results. by Kevin J. Mills (9270966)

Subjects:

Fatty acids, triacylglycerol and ketone body metabolism CKO vs K5Cre Reactome. by Kevin J. Mills (9270966)

Subjects:

Phospholipid metabolism CKO vs K5Cre Reactome. by Kevin J. Mills (9270966)

Subjects:

Cholesterol biosynthetic process CKO vs K5Cre GO: Biological Processes. by Kevin J. Mills (9270966)

Subjects:

Targeted analysis of cholesterol and cholesterol esters in epidermis reveals changes in specific cholesterol esters in CKO epidermis. by Kevin J. Mills (9270966)

Subjects:

Localization and conditional deletion of C/EBP in SKH1 mouse epidermis. by Kevin J. Mills (9270966)

Subjects:

Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013. by Qian Cai (112039)

Subjects:

The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019. by Qian Cai (112039)

Subjects:

Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. by Qian Cai (112039)

Subjects:

Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. by Qian Cai (112039)

Subjects:

Flowchart of the study population. by Gábor Szaló (22615130)

“…Among those 803 individuals who did not take antihypertensive medication, there was a significant association in linear regression between increase in PSS-10 and decrease in C2 (B: −0.2, 95% CI: −0.4- −0.02; p = 0.03) that was lost after adjustment for physical activity (B: −0.16, 95% CI: −0.35–0.03; p = 0.1). …”

Characteristics of study population. by Gábor Szaló (22615130)

“…Among those 803 individuals who did not take antihypertensive medication, there was a significant association in linear regression between increase in PSS-10 and decrease in C2 (B: −0.2, 95% CI: −0.4- −0.02; p = 0.03) that was lost after adjustment for physical activity (B: −0.16, 95% CI: −0.35–0.03; p = 0.1). …”

ROBINS-I assessments. by Martha R. Smith (20410184)

Subjects:

S8 File - by Martha R. Smith (20410184)

Subjects:

Study populations of included studies. by Martha R. Smith (20410184)

Subjects: